Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication.

Hwang JJ, Lee DH, Yoon H, Shin CM, Park YS, Kim N.

World J Gastroenterol. 2015 Sep 21;21(35):10234-41. doi: 10.3748/wjg.v21.i35.10234.

2.

Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.

Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N.

World J Gastroenterol. 2015 Jul 14;21(26):8132-9. doi: 10.3748/wjg.v21.i26.8132.

3.

Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.

Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N.

World J Gastroenterol. 2015 May 14;21(18):5568-74. doi: 10.3748/wjg.v21.i18.5568.

4.

Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.

Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N.

World J Gastroenterol. 2015 Apr 28;21(16):5032-8. doi: 10.3748/wjg.v21.i16.5032.

5.

Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.

Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N.

World J Gastroenterol. 2015 Apr 28;21(16):4954-60. doi: 10.3748/wjg.v21.i16.4954.

6.

Eradication rate and histological changes after Helicobacter pylori eradication treatment in gastric cancer patients following subtotal gastrectomy.

Hwang JJ, Lee DH, Kang KK, Lee AR, Yoon H, Shin CM, Park YS, Kim N.

World J Gastroenterol. 2015 Apr 7;21(13):3936-43. doi: 10.3748/wjg.v21.i13.3936.

Supplemental Content

Loading ...
Support Center